Hemoadsorption as a Supportive Strategy for Severe Toxicity Associated With Chimeric Antigen Receptor T-Cell Therapy: A Case Series
A strategy based on hemoadsorption was safe and effective in mitigating inflammation and improving hemodynamics in patients with hematological cancer treated with CAR-T therapy who developed early severe toxicity.
Authors
- Anna Maria Raiola (ORCID: https://orcid.org/0000-0002-5118-4167)
- Novella Conti
- Pasquale B. Esposito (ORCID: https://orcid.org/0000-0002-0834-5586)
- Francesca Viazzi (ORCID: https://orcid.org/0000-0003-4219-7043)
- Stefania Bianzina (ORCID: https://orcid.org/0000-0003-1867-8023)
- Massimiliano Gambella (ORCID: https://orcid.org/0000-0002-7896-4198)
- Elisa Porcile
- Elisa Russo (ORCID: https://orcid.org/0000-0003-1279-3178)
- Emanuele Angelucci (ORCID: https://orcid.org/0000-0002-6512-6080)
- Monica Centanaro
- Elena Beltrametti
Institutions
- Istituto Giannina Gaslini (IT)
- Ospedale Policlinico San Martino (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Kidney Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.xkme.2025.101001
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05